BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 30307707)

  • 1. Potential influence of p16 immunohistochemical staining on the diagnosis of squamous cell lesions in cervical biopsy specimens: observation from cytologic-histologic correlation.
    Yang J; Elliott A; Hoffa AL; Herring N; Houser PM
    Cancer Cytopathol; 2018 Dec; 126(12):1003-1010. PubMed ID: 30307707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of p16 Immunohistochemistry in Evaluating Negative Cervical Biopsies Following High-risk Pap Test Results.
    Shain AF; Kwok S; Folkins AK; Kong CS
    Am J Surg Pathol; 2018 Jan; 42(1):69-75. PubMed ID: 29112019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p16 Immunohistochemistry is useful in confirming high-grade squamous intraepithelial lesions (HSIL) in women with negative HPV testing.
    Zhang G; Yang B; Abdul-Karim FW
    Int J Gynecol Pathol; 2015 Mar; 34(2):180-6. PubMed ID: 25675189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program.
    Gustinucci D; Passamonti B; Cesarini E; Butera D; Palmieri EA; Bulletti S; Carlani A; Staiano M; D'Amico MR; D'Angelo V; Di Dato E; Martinelli N; Malaspina M; Spita N; Tintori B; Fulciniti F
    Acta Cytol; 2012; 56(5):506-14. PubMed ID: 23075891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined detection of p16(INK4a) and IMP3 increase the concordance rate between cervical cytologic and histologic diagnosis.
    Wei Q; Fu B; Liu J; Xu J; Zhao T
    Int J Clin Exp Pathol; 2013; 6(8):1549-57. PubMed ID: 23923073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of p16/Ki-67 double immunocytochemical staining in cervical cytology ASCUS, LSIL, and ASC-H].
    Wu Y; Zhao J; Hu J; Wu XW; Zhu LR
    Zhonghua Fu Chan Ke Za Zhi; 2017 Nov; 52(11):734-739. PubMed ID: 29179267
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical value of p16
    Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF
    Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350
    [No Abstract]   [Full Text] [Related]  

  • 8. Overdiagnosis of HSIL on cervical biopsy: errors in p16 immunohistochemistry implementation.
    Clark JL; Lu D; Kalir T; Liu Y
    Hum Pathol; 2016 Sep; 55():51-6. PubMed ID: 27134110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p16 staining has limited value in predicting the outcome of histological low-grade squamous intraepithelial lesions of the cervix.
    Sagasta A; Castillo P; Saco A; Torné A; Esteve R; Marimon L; Ordi J; Del Pino M
    Mod Pathol; 2016 Jan; 29(1):51-9. PubMed ID: 26541274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of deeper levels and ancillary studies (p16(Ink4a) and ProExC) in reducing the discordance rate of Papanicolaou findings of high-grade squamous intraepithelial lesion and follow-up cervical biopsies.
    David O; Cabay RJ; Pasha S; Dietrich R; Leach L; Guo M; Mehrotra S
    Cancer; 2009 Jun; 117(3):157-66. PubMed ID: 19521978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical assessment of p16, COX-2 and EGFR in HPV-positive cervical squamous intraepithelial lesions.
    Balan R; Simion N; Giuşcă SE; Grigoraş A; Gheucă-Solovăstru L; Gheorghiţă V; Amălinei C; Căruntu ID
    Rom J Morphol Embryol; 2011; 52(4):1187-94. PubMed ID: 22203921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficiency of immunohistochemical p16 expression and HPV typing in cervical squamous intraepithelial lesion grading and review of the p16 literature.
    Yildiz IZ; Usubütün A; Firat P; Ayhan A; Küçükali T
    Pathol Res Pract; 2007; 203(6):445-9. PubMed ID: 17543474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is p16(INK4A) expression more useful than human papillomavirus test to determine the outcome of atypical squamous cells of undetermined significance-categorized Pap smear? A comparative analysis using abnormal cervical smears with follow-up biopsies.
    Nieh S; Chen SF; Chu TY; Lai HC; Lin YS; Fu E; Gau CH
    Gynecol Oncol; 2005 Apr; 97(1):35-40. PubMed ID: 15790434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thin HSIL of the Cervix: Detecting a Variant of High-grade Squamous Intraepithelial Lesions With a p16INK4a Antibody.
    Reich O; Regauer S
    Int J Gynecol Pathol; 2017 Jan; 36(1):71-75. PubMed ID: 27513079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective evaluation of p16/Ki-67 dual-stained cytology for managing women with abnormal Papanicolaou cytology: PALMS study results.
    Bergeron C; Ikenberg H; Sideri M; Denton K; Bogers J; Schmidt D; Alameda F; Keller T; Rehm S; Ridder R;
    Cancer Cytopathol; 2015 Jun; 123(6):373-81. PubMed ID: 25891096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hierarchical evaluation of histology and p16-labeling can improve the risk assessment on cervical intraepithelial neoplasia progression.
    Medeiros FS; Dos Santos Gomes FO; Paiva LA; da Silva NCH; da Silva MC; Rygaard MCV; Peixoto CA; Welkovic S; Menezes MLB; Cokan A; Diniz GTN; Donadi EA; Lucena-Silva N
    Exp Mol Pathol; 2022 Feb; 124():104734. PubMed ID: 34914974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p16INK4a immunohistochemical and histopathologic study of Pap test cases interpreted as HSIL without CIN2-3 identification in subsequent cervical specimens.
    Solano FJ; Rush DS; Wilkinson EJ
    Int J Gynecol Pathol; 2015 May; 34(3):215-20. PubMed ID: 25844545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of p16INK4a immunoexpression and human papillomavirus (HPV) detected by in-situ hybridization in cervical squamous neoplasia.
    Cheah PL; Koh CC; Nazarina AR; Teoh KH; Looi LM
    Malays J Pathol; 2016 Apr; 38(1):33-8. PubMed ID: 27126662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.
    Juric D; Mahovlić V; Rajhvajn S; Ovanin-Rakić A; Skopljanac-Macina L; Barisić A; Projić IS; Babić D; Susa M; Corusić A; Oresković S
    Coll Antropol; 2010 Mar; 34(1):19-24. PubMed ID: 20432728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the Biomarker p16 in Downgrading -IN 2 Diagnoses and Predicting Higher-grade Lesions.
    Maniar KP; Sanchez B; Paintal A; Gursel DB; Nayar R
    Am J Surg Pathol; 2015 Dec; 39(12):1708-18. PubMed ID: 26371784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.